Drugs Controller General of India Current Affairs, GK & News

India: Expert panel recommends approval to Sputnik V vaccine

April 13, 2021

An Expert panel of the Central Drugs Standard Control Organisation (CDSCO) recently approved the Emergency Use of COVID-19 vaccine Sputnik-V. However, the Drugs Controller General of India (DGCI) is to take a final call on the recommendation. When approved, Sputnik will be the third COVID-19 vaccine to be available in India. Sputnik V Vaccine The ..

Month: 

Category: 

Topics:  • • • • •

DCGI approves Favipiravir for treating COVID-19

June 20, 2020

The drugs controller general of India (DGCI) granted approval to Glenmark Pharmaceuticals to manufacture and market oral antiviral drug Favipiravir to treat mild and moderate COVID-19 cases in India. The drug will be marketed under the brand name ‘FabiFlu’. It is known to prevent the virus from replication. In Japan, the drug is sold under ..

Month: 

Topics:  • •

Clinical trial begins of plant based drug for Covid-19

June 6, 2020

On 5th June, 2020, the Drugs Controller General of India allowed Sun Pharmaceutical to conduct trial for the first phytopharmaceutical or plant based drug AQCH to treat covid-19 patients. The trial has begun by Sun pharmaceutical in collaboration with ICGEB New Delhi and CSIR IIIM Jammu with support by CSIR and DBT. Mumbai based Sun ..

Topics:  • • •

DCGI allows Indian firm to conduct phase 1 trials for Zika vaccine

December 19, 2017

The Drugs Controller General of India (DCGI) has granted permission to Indian firm to conduct Phase-I clinical trials for a Zika vaccine. It was announced by Union Minister of State (MoS) for Health and Family Welfare Ashwini Kumar Choubey in Lok Sabha. Zika Virus Zika Virus is vector borne diseases spread by Aedes egypti mosquito. ..

Month: 

Topics:  • • • • •